Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder
← Find more feeds

ema.europa.eu

Human medicines: European public assessment reports (EPARs)

Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.

Follow now 199 followers

Latest posts

Last updated 42 minutes ago

Human medicines European public assessment report (EPAR): Foclivia, pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), Influenza, Human;Immunization;Disease Outbreaks, Date of authorisation: 18/10/2009, Revision: 13, Status: Aut

42 minutes ago

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Esophageal Squamous Cell Carcinoma, Date of authorisation: 15/09/2023, Status: Authorised

about 22 hours ago

Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis, Date of authorisation: 15/09/2023, Status: Authori

about 22 hours ago

Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Dermatitis, Atopic, Date of authorisation: 17/06/2021, Revision: 3, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Dafiro HCT, amlodipine besilate,valsartan,hydrochlorothiazide, Hypertension, Date of authorisation: 03/11/2009, Revision: 26, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Radionuclide Imaging, Date of authorisation: 09/12/2022, Revision: 2, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Waldenstrom Macroglobulinemia, Date of authorisation: 22/11/2021, Revision: 7, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Exforge HCT, amlodipine besilate,valsartan,hydrochlorothiazide, Hypertension, Date of authorisation: 15/10/2009, Revision: 24, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Docetaxel Kabi, docetaxel, Head and Neck Neoplasms;Carcinoma, Non-Small-Cell Lung;Adenocarcinoma;Prostatic Neoplasms;Breast Neoplasms, Date of authorisation: 22/05/2012, Revision: 15, Status: Autho

4 days ago

Human medicines European public assessment report (EPAR): Lyfnua, gefapixant, Cough, Date of authorisation: 15/09/2023, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Neuroendocrine Tumors;Radionuclide Imaging, Date of authorisation: 08/12/2016, Revision: 15, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Hepatitis D, Chronic, Date of authorisation: 31/07/2020, Revision: 11, Status: Authorised

5 days ago

Sign up to continue

Try Feeder for free

Everything you care about in one place

Try Feeder now